PARP9 and PARP14 as key regulators of macrophage activation
US11739331B2 · kind B2 · utility
0Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 14, 2020 |
| Grant date | Aug 29, 2023 |
| Priority date | — |
| Expiry date | Apr 25, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y204/0203
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to compositions and methods for inhibiting macrophage activation via modulating PARP9 and/or PARP14 expression or activity, such as small molecules, RNAi and antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.